Meeting
2024 ASCO Genitourinary Cancers Symposium
Prevalence of variant of unknown significance (VUS) in men with prostate cancer who serve as a benchmark for enhanced screening and for personalized therapy.
Authors
Vittorio Fasulo
Humanitas University, Pieve Emanuele, Italy
Vittorio Fasulo , Massimo Lazzeri , Paolo Casale , Alberto Saita , Rodolfo Hurle , Marco Paciotti , Alessio Finocchiaro , Muhannad Aljoulani , Pietro Cavalli , Giulia Soldà , Ilaria De Simone , Piergiuseppe Colombo , Miriam Cieri , Federica Maura , Giovanni Lughezzani , Rosanna Asselta , Nicolò Maria Buffi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Other
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 342)
DOI
10.1200/JCO.2024.42.4_suppl.342
Abstract #
342
Poster Bd #
P11
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Inherited risk for prostate cancer (PCa): Following the natural history of men with high-risk genetics using multiparametric MRI (mpMRI).
First Author: Anna Couvillon
Poster
2023 ASCO Genitourinary Cancers Symposium
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
First Author: Channing Judith Paller
Poster
2022 ASCO Annual Meeting
Retrospective analysis of non-BRCA gene pathogenicity variation in Chinese patients with ovarian cancer.
First Author: Li yuan Guo
Poster
2022 ASCO Genitourinary Cancers Symposium
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
First Author: Channing Judith Paller